{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-16&max-date=2019-07-09", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2019-07-16&max-date=2019-07-09", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-16&max-date=2019-07-09&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2019-07-16&max-date=2019-07-09", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-16&max-date=2019-07-09", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2019-07-16&max-date=2019-07-09", "items" : [{"_about" : "http://data.parliament.uk/resources/1137731", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137731/answer", "answerText" : {"_value" : "
Many National Health Service trusts use framework agreements for the procurement of translation services which are put in place either by Crown Commercial Service or their local procurement hub. These central purchasing bodies undertake assessments of companies to ensure that they meet the minimum standards and are able to track performance across a number of NHS trusts.<\/p>
The Department does not review NHS procurement practices on a trust by trust basis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-16T08:43:29.847Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Sign Language"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the procurement processes operated by NHS trusts for the purpose of hiring British Sign Language translators.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4139", "label" : {"_value" : "Biography information for Ian Lavery"} } , "tablingMemberConstituency" : {"_value" : "Wansbeck"} , "tablingMemberPrinted" : [{"_value" : "Ian Lavery"} ], "uin" : "275195"} , {"_about" : "http://data.parliament.uk/resources/1137734", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137734/answer", "answerText" : {"_value" : "
Leaving the EU does not change the UK's commitment to domestic and international action to tackle climate change. On 27 June, the UK became the first major economy in the world to set a legally binding target to achieve net zero greenhouse gas emissions from across the UK economy by 2050. We will continue to work closely with our European and other international partners to secure ambitious climate objectives. We will do this through continued cooperation in multilateral groups - including the UNFCCC, G7, G20, the Commonwealth and the International Energy Agency \u2013 as well as continued strong bilateral relationships on climate with countries around the world. Our recent bid to host COP26 in 2020, under a UK Presidency in partnership with Italy, demonstrates our continued commitment to play a global leadership role in galvanising action on climate change.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4021", "label" : {"_value" : "Biography information for Chris Skidmore"} } , "answeringMemberConstituency" : {"_value" : "Kingswood"} , "answeringMemberPrinted" : {"_value" : "Chris Skidmore"} , "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-16T16:41:01.037Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Climate Change: International Cooperation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he has taken to preserve international co-operation on climate change when the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4139", "label" : {"_value" : "Biography information for Ian Lavery"} } , "tablingMemberConstituency" : {"_value" : "Wansbeck"} , "tablingMemberPrinted" : [{"_value" : "Ian Lavery"} ], "uin" : "275197"} , {"_about" : "http://data.parliament.uk/resources/1137738", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137738/answer", "answerText" : {"_value" : "
The availability of treatments in Scotland is a matter for the devolved administration.<\/p>
In England, the National Institute for Health and Care Excellence (NICE) is the independent body that develops authoritative, evidence-based guidance on best practice in health and social care. NICE\u2019s guideline on the assessment, management and support for people living with dementia and their carers, published in 2018, recommends that Circadin (melatonin) should not be offered to manage insomnia in people living with Alzheimer's disease, and that a personalised multicomponent sleep management approach that includes sleep hygiene education, exposure to daylight, exercise and personalised activities should be considered for people living with dementia who have sleep problems.<\/p>
Further information about the evidence underpinning NICE\u2019s guideline is available at the following link:<\/p>
https://www.nice.org.uk/guidance/ng97/evidence/full-guideline-pdf-4852695709<\/a><\/p> NICE does not make recommendations on the use of melatonin in the treatment of patients living with other types of dementia who have sleep problems.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "275217"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-16T14:42:57.797Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Insomnia: Melatonin"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reasons Circadin is available in Scotland for the treatment of insomnia caused as a result of dementia but not in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4396", "label" : {"_value" : "Biography information for Rebecca Long Bailey"}
}
, "tablingMemberConstituency" : {"_value" : "Salford and Eccles"}
, "tablingMemberPrinted" : [{"_value" : "Rebecca Long Bailey"}
], "uin" : "275216"}
, {"_about" : "http://data.parliament.uk/resources/1137739", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1137739/answer", "answerText" : {"_value" : " The availability of treatments in Scotland is a matter for the devolved administration.<\/p> In England, the National Institute for Health and Care Excellence (NICE) is the independent body that develops authoritative, evidence-based guidance on best practice in health and social care. NICE\u2019s guideline on the assessment, management and support for people living with dementia and their carers, published in 2018, recommends that Circadin (melatonin) should not be offered to manage insomnia in people living with Alzheimer's disease, and that a personalised multicomponent sleep management approach that includes sleep hygiene education, exposure to daylight, exercise and personalised activities should be considered for people living with dementia who have sleep problems.<\/p> Further information about the evidence underpinning NICE\u2019s guideline is available at the following link:<\/p> https://www.nice.org.uk/guidance/ng97/evidence/full-guideline-pdf-4852695709<\/a><\/p> NICE does not make recommendations on the use of melatonin in the treatment of patients living with other types of dementia who have sleep problems.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "275216"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-16T14:42:57.843Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Insomnia: Melatonin"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to make Circadin available in England to people suffering from insomnia caused by dementia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4396", "label" : {"_value" : "Biography information for Rebecca Long Bailey"}
}
, "tablingMemberConstituency" : {"_value" : "Salford and Eccles"}
, "tablingMemberPrinted" : [{"_value" : "Rebecca Long Bailey"}
], "uin" : "275217"}
, {"_about" : "http://data.parliament.uk/resources/1137753", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1137753/answer", "answerText" : {"_value" : " The Government is committed to supporting all entrepreneurs to start and grow a business. Through our ambitious Industrial Strategy, we want to make the UK the best place to start and grow a business, to create jobs and spread prosperity.<\/p> In addition to accessing national support available such as the Business Support Helpline (0300 456 3565) and advice given on www.gov.uk<\/a>, small and medium sized enterprises in Yorkshire and the Humber can access business advice through their local Growth Hubs. Led and governed by Local Enterprise Partnerships (LEPs), Growth Hubs provide a free, impartial, \u2018single point of contact\u2019 to help businesses in the area identify and access the right support for them at the right time no matter their size or sector. The LEPs which cover Yorkshire and the Humber have self-reported that in FY2017-2018 their Growth Hubs supported over 12,000\u202fbusinesses and helped over 900 individuals start a business.<\/p> The Humber LEP area is being supported with up to £83.4m of investment through the Regional Growth Fund, which includes £30m awarded to the Humber LEP for a business support programme. The Growing Places Fund is supporting business growth investment across the Humber with funding worth £8.8m. The Humber LEP\u2019s \u2018Growing the Humber\u2019 business investment programme has supported the creation of over 2,800 jobs to date.<\/p> The Government-backed British Business Bank\u2019s Start-Up Loans programme provides loans to entrepreneurs seeking to start and grow their own businesses. Since 2012, 5,482 loans have been issued in the Yorkshire and the Humber region, totalling over £45m, and with an average loan amount of £8,249. In the Haltemprice and Howden constituency, 103 loans have been issued, totalling £926,277 (as at end-June 2019).<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4487", "label" : {"_value" : "Biography information for Kelly Tolhurst"}
}
, "answeringMemberConstituency" : {"_value" : "Rochester and Strood"}
, "answeringMemberPrinted" : {"_value" : "Kelly Tolhurst"}
, "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-16T16:40:47.44Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Small Businesses: Yorkshire and the Humber"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent steps he has taken to support small businesses in (a) Yorkshire and the Humber and (b) Haltemprice and Howden constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"}
}
, "tablingMemberConstituency" : {"_value" : "Haltemprice and Howden"}
, "tablingMemberPrinted" : [{"_value" : "Mr David Davis"}
], "uin" : "275117"}
, {"_about" : "http://data.parliament.uk/resources/1137754", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1137754/answer", "answerText" : {"_value" : " Pre-exposure prophylaxis (PrEP) is not currently a routinely commissioned service, but is provided by the National Health Service through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "275199"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-16T14:43:12.737Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "HIV Infection: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, for what reason the Morpeth Clinic, Northumberland Sexual Health Services to not provide services to Gay and Bisexual men on the PrEP impact trial.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4139", "label" : {"_value" : "Biography information for Ian Lavery"}
}
, "tablingMemberConstituency" : {"_value" : "Wansbeck"}
, "tablingMemberPrinted" : [{"_value" : "Ian Lavery"}
], "uin" : "275198"}
, {"_about" : "http://data.parliament.uk/resources/1137755", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1137755/answer", "answerText" : {"_value" : " Pre-exposure prophylaxis (PrEP) is not currently a routinely commissioned service, but is provided by the National Health Service through the three year PrEP Impact Trial. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "275198"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-16T14:43:12.783Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "HIV Infection: Morpeth"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that Gay and Bisexual men accessing the Morpeth Clinic, Northumberland Sexual Health Services have access to PrEP.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4139", "label" : {"_value" : "Biography information for Ian Lavery"}
}
, "tablingMemberConstituency" : {"_value" : "Wansbeck"}
, "tablingMemberPrinted" : [{"_value" : "Ian Lavery"}
], "uin" : "275199"}
, {"_about" : "http://data.parliament.uk/resources/1137758", "AnsweringBody" : [{"_value" : "Home Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1137758/answer", "answerText" : {"_value" : "